Dr Stanislaw Burzynski is the first and only scientist in United States history to enter the federal drug approval process for a proprietary cancer therapy without any support from the American government, the pharmaceutical industry, or any other entity within the cancer establishment….and they don’t like that.
Stanislaw Burzynski, M.D. is a physician and biochemist who pioneered the development and use of biologically active peptides for the treatment of cancer.
In 1967, at the young age of 24, he first identified these naturally occurring peptides, which he found were lacking in those with cancer. He later developed a therapy known as antineoplastons, which can be used to turn on the cancer fighting mechanisms within the body. These treatments have no ill side effects and can boast a 30-50% survival rate for children and adults diagnosed with terminal brain cancers after standard conventional treatments have failed them. .
Burzynski has completed phase 1 and 11 clinical trials of antineoplastons for pediatric brain tumors and would like to begin phase 3, but so far the FDA has been uncooperative. The FDA has had longstanding restrictions in place demanding that children diagnosed with brain cancers must first go through conventional treatments and fail before they can qualify to be in the antineoplaston pediatric brain cancer trials. Additionally, for the past several years the FDA has decided who can be treated with antineoplastons and who could not, and they appear to have done so arbitrarily. Since January of 2013, the FDA has placed further restrictions on his ability to accept and treat all patients with antineoplastons, no matter what their age or diagnosis. You may have seen petitions circulating lately from patients wishing to ask the FDA to approve their case under the realm of “compassionate care,” however this strategy does not appear to be working as the FDA has been rejecting them too.
Burzynksi does not claim to cure all cancers, in fact he is very upfront about the abilities of antineoplastons. He says, “Some cancers have a higher response rate than others, but overall, our success rate is any where from 40-60%. These statistics represent, in their majority, people who were initially given a terminal diagnosis and who came to us after conventional treatments failed them. For certain types of brain tumors, we have an over 60 percent partial or complete response rate. For malignant melanoma, we have an objective response rate of around 40%.” (note-currently there is no effective standard treatment for malignant melanoma).
Why does Burzynski charge patients to be in drug trials? Many people have questioned why Dr Burzynski must charge his patients in order to participate in these clinical trials. The answer is that cash-rich drug companies can afford to fund their own clinical trials that carry a 300 million dollar price tag. Pharmaceutical companies will also qualify for research grants from the National Cancer Institute, National Institute of Health, or the American Cancer Society once the complete phase one clinical trials to help with the astronomical costs. In contrast, Dr Burzynski has never received a penny from any of these organizations even when he finished up phase one and phase 2 trials, instead he has had to spend millions of dollars having to defend himself from charges filed by the FDA regarding the use of antineoplaston treatments. One would think that these organizations would be happy that a non-toxic cure for cancer has been discovered, but instead they have chosen to prosecute him relentlessly. How does the conventional camp explain away the thousands of patients who continue to rally in his defense? They have chosen to ignore them or come up with various explanations as to why their cancers were cured and have managed to sweep them all away.
NCI holds fraudulent drug trials while attempting to steal Burzynski’s drug patents- The only pseudo-support that he did receive was when the National Cancer Institute offered to put antineoplastons through human trials, but it turns out that they were only being put on to discredit him.
Directives given by Burzynski regarding the amount of antineoplastons to administer and the duration of the treatment were not followed and to their shame, a dozen people died while the National Cancer Institute toyed with their lives. The Burzynksi documentary also reveals how the FDA attempted to steal his patents while at the same time outwardly rejecting his therapy and prosecuting him, yet the actual patent applications that were filed very clearly stated that antineoplaston treatments are effective for many forms of cancer including breast, prostate, liver, colon, lung, melanoma and others.
Insurance reimbursements- Patients who are not approved for antineoplastons therapy can go to the Burzynski Research Institute to consult with Dr Burzynski, there they will receive a complete gene screening which will identify the oncogenes responsible for the growth of cancerous cells (these tests are currently not available at standard care cancer clinics in the US). Dr Burzynski then provides patients with a targeted treatment plan which will address the specific cancer cells that are carrying the identified abnormal genes. This means that specific cancers may have the genetic makeup of another, so they are treated with the appropriate drug that the cancer will respond to, not the one size fits all oncology that is the norm in the U.S. The main goal with gene screening is to personalize the treatments used to match the patient’s needs in order to achieve maximum effectiveness with minimum side effects. A few insurance companies will pay for some of the treatments offered at the center, but since Dr Burzynski often prescribes off-label chemotherapeutic treatments, this may also complicate matters with insurance company reimbursements.
Over the past few decades Dr Burzynksi has had to spend millions of dollars defending himself against the various charges that have been brought against him, and on November 19, 2012, judges at the Texas State Office of Administrative Hearings dismissed the last case that was filed by the Texas Medical Board for prescribing and treating patients with off label gene-targeted protocols. But that court victory has still not allowed him to practice his form of medicine on patients with cancer, and he is under more pressure now than ever from his detractors.
Finding Antineoplaston treatments outside of the US- antineoplaston therapy in now available in Japan. Any patient with any type of cancer can go to Japan to get Antineoplaston therapy legally, and can completely avoid FDA regulations altogether. Regardless of cancer type, and regardless of “previous therapy”. The only problem is that it is very expensive because the only way they can legally give ANP infusions is in a hospital setting (vs doing them at home as done through Burzynski Clinic). But if someone can afford it, the option is always available: http://www.cancerclinic.jp/en/cancer_treatments/antineoplaston.html
(713) 335-5697 or e-mail questions to firstname.lastname@example.org.
Dr Burzynski on Dateline
Dr Chen details the corruption that occurred at the National Cancer Institute after writing a report that was favorable to Burzynksi’s therapy.
Trailer for the second Burzyski documentary
A father shares his story of attempting to obtain Burzynski’s therapy for his daughter’s brain cancer and being denied by the FDA. She died because of this.
Dustin Kunnari Beats brain cancer with Burzynski Antineoplastons
Schad Kolar shares his diagnosed with Gardner’s Syndrome, a genetic disease that causes polyps to grow unchecked on internal organs. Conventional treatments failed to treat him, but Dr Burzynski offered him a complete cure.
News report on Sophia who was diagnosed with a rare brain tumor as a baby. Hospice was called as there was nothing more that could be done until Dr Burzynski’s Antineoplaston therapy was used. She is now 16!
Sophia Gettino is a former patient of the Burzynski Clinic who was told by conventional doctors that she wouldn’t live to see her second birthday because her brain was riddled with tumors. In January 2012, ABC News Channel 9 in New York had her featured as she celebrated her sweet 16th birthday still cancer free.